This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thomas, W. G. Articles by Baker, K. M. Search for Related Content PubMed PubMed Citation Articles by Thomas, W. G. Articles by Baker, K. M.

Phosphorylation of the Angiotensin II (AT_1A) Receptor Carboxyl Terminus: A Role in Receptor Endocytosis

Weis Center for Research (T.J.M., C.E.K., V.K., K.M.B.) Geisinger Clinic Danville, Pennsylvania 17822
Baker Medical Research Institute (W.G.T.) Melbourne 8008, Australia

The molecular mechanism of angiotensin II type I receptor (AT₁) endocytosis is obscure, although the identification of an important serine/threonine rich region (Thr³³²Lys³³³Met³³⁴Ser³³⁵Thr³³⁶Leu³³⁷Ser³³⁸) within the carboxyl terminus of the AT_1A receptor subtype suggests that phosphorylation may be involved. In this study, we examined the phosphorylation and internalization of full-length AT_1A receptors and compared this to receptors with truncations and mutations of the carboxyl terminus. Epitope-tagged full-length AT_1A receptors, when transiently transfected in Chinese hamster ovary (CHO)-K1 cells, displayed a basal level of phosphorylation that was significantly enhanced by angiotensin II (Ang II) stimulation. Phosphorylation of AT_1A receptors was progressively reduced by serial truncation of the carboxyl terminus, and truncation to Lys³²⁵, which removed the last 34 amino acids, almost completely inhibited Ang II-stimulated ³²P incorporation into the AT_1A receptor. To investigate the correlation between receptor phosphorylation and endocytosis, an epitope-tagged mutant receptor was produced, in which the carboxyl-terminal residues, Thr³³², Ser³³⁵, Thr³³⁶, and Ser³³⁸, previously identified as important for receptor internalization, were substituted with alanine. Compared with the wild-type receptor, this mutant displayed a clear reduction in Ang II-stimulated phosphorylation. Such a correlation was further strengthened by the novel observation that the Ang II peptide antagonist, Sar¹Ile⁸-Ang II, which paradoxically causes internalization of wild-type AT_1A receptors, also promoted their phosphorylation. In an attempt to directly relate phosphorylation of the carboxyl terminus to endocytosis, the internalization kinetics of wild-type AT_1A receptors and receptors mutated within the Thr³³²-Ser³³⁸ region were compared. The four putative phosphorylation sites (Thr³³², Ser³³⁵, Thr³³⁶, and Ser³³⁸) were substituted with either neutral [alanine (A)] or acidic amino acids [glutamic acid (E) and aspartic acid (D)], the former to prevent phosphorylation and the latter to reproduce the acidic charge created by phosphorylation. Wild-type AT_1A receptors, expressed in Chinese hamster ovary cells, rapidly internalized after Ang II stimulation [t_1/2 2.3 min; maximal level of internalization (Y_max) 78.2%], as did mutant receptors carrying single acidic substitutions (T332E, t_1/2 2.7 min, Y_max 76.3%; S335D, t_1/2 2.4 min, Y_max 76.7%; T336E, t_1/2 2.5 min, Y_max 78.2%; S338D, t_1/2 2.6 min, Y_max 78.4%). While acidic amino acid substitutions may simply be not as structurally disruptive as alanine mutations, we interpret the tolerance of a negative charge in this region as suggestive that phosphorylation may permit maximal internalization. Substitution of all four residues to alanine produced a receptor with markedly reduced internalization kinetics (T332A/S335A/T336A/S338A, t_1/2 10.1 min, Y_max 47.9%), while endocytosis was significantly rescued in the corresponding quadruple acidic mutant (T332E/S335D/T336E/S338D, t_1/2 6.4 min, Y_max 53.4%). Double mutation of S335 and T336 to alanine also diminished the rate and extent of endocytosis (S335A/T336A, 3.9 min, Y_max 69.3%), while the analogous double acidic mutant displayed wild type-like endocytotic parameters (S335D/T336E, t_1/2 2.6 min, Y_max 77.5%). Based on the apparent rescue of internalization by acidic amino acid substitutions in a region that we have identified as a site of Ang II-induced phosphorylation, we conclude that maximal endocytosis of the AT_1A receptor requires phosphorylation within this serine/threonine-rich segment of the carboxyl terminus.

This article has been cited by other articles:

				M. Mogi, M. Iwai, and M. Horiuchi Emerging Concepts of Regulation of Angiotensin II Receptors: New Players and Targets for Traditional Receptors Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2532 - 2539. [Abstract] [Full Text] [PDF]

				L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure Physiol Rev, April 1, 2007; 87(2): 565 - 592. [Abstract] [Full Text] [PDF]

				A. M. Allen, J. K. Dosanjh, M. Erac, S. Dassanayake, R. D. Hannan, and W. G. Thomas Expression of Constitutively Active Angiotensin Receptors in the Rostral Ventrolateral Medulla Increases Blood Pressure Hypertension, June 1, 2006; 47(6): 1054 - 1061. [Abstract] [Full Text] [PDF]

				D. T. Dinh, H. Qian, R. Seeber, E. Lim, K. Pfleger, K. A. Eidne, and W. G. Thomas Helix I of {beta}-Arrestin Is Involved in Postendocytic Trafficking but Is Not Required for Membrane Translocation, Receptor Binding, and Internalization Mol. Pharmacol., February 1, 2005; 67(2): 375 - 382. [Abstract] [Full Text] [PDF]

				K. Ronacher, N. Matsiliza, N. Nkwanyana, A. J. Pawson, T. Adam, C. A. Flanagan, R. P. Millar, and A. A. Katz Serine Residues 338 and 339 in the Carboxyl-Terminal Tail of the Type II Gonadotropin-Releasing Hormone Receptor Are Critical for {beta}-Arrestin-Independent Internalization Endocrinology, October 1, 2004; 145(10): 4480 - 4488. [Abstract] [Full Text] [PDF]

				A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF]

				B. N. Becker, H.-f. Cheng, T. G. Hammond, and R. C. Harris The Type 1 Angiotensin II Receptor Tail Affects Receptor Targeting, Internalization, and Membrane Fusion Properties Mol. Pharmacol., February 1, 2004; 65(2): 362 - 369. [Abstract] [Full Text] [PDF]

				B. D. Wyse, I. A. Prior, H. Qian, I. C. Morrow, S. Nixon, C. Muncke, T. V. Kurzchalia, W. G. Thomas, R. G. Parton, and J. F. Hancock Caveolin Interacts with the Angiotensin II Type 1 Receptor during Exocytic Transport but Not at the Plasma Membrane J. Biol. Chem., June 20, 2003; 278(26): 23738 - 23746. [Abstract] [Full Text] [PDF]

				Z. Gaborik, G. Jagadeesh, M. Zhang, A. Spat, K. J. Catt, and L. Hunyady The Role of a Conserved Region of the Second Intracellular Loop in AT1 Angiotensin Receptor Activation and Signaling Endocrinology, June 1, 2003; 144(6): 2220 - 2228. [Abstract] [Full Text] [PDF]

				A. C. Holloway, H. Qian, L. Pipolo, J. Ziogas, S.-i. Miura, S. Karnik, B. R. Southwell, M. J. Lew, and W. G. Thomas Side-Chain Substitutions within Angiotensin II Reveal Different Requirements for Signaling, Internalization, and Phosphorylation of Type 1A Angiotensin Receptors Mol. Pharmacol., April 1, 2002; 61(4): 768 - 777. [Abstract] [Full Text] [PDF]

				B. H. Shah, J. Alberto Olivares-Reyes, A. Yesilkaya, and K. J. Catt Independence of Angiotensin II-Induced MAP Kinase Activation from Angiotensin Type 1 Receptor Internalization in Clone 9 Hepatocytes Mol. Endocrinol., March 1, 2002; 16(3): 610 - 620. [Abstract] [Full Text] [PDF]

				W. G. Thomas, Y. Brandenburger, D. J. Autelitano, T. Pham, H. Qian, and R. D. Hannan Adenoviral-Directed Expression of the Type 1A Angiotensin Receptor Promotes Cardiomyocyte Hypertrophy via Transactivation of the Epidermal Growth Factor Receptor Circ. Res., February 8, 2002; 90(2): 135 - 142. [Abstract] [Full Text] [PDF]

				C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF]

				H. Qian, L. Pipolo, and W. G. Thomas Association of {beta}-Arrestin 1 with the Type 1A Angiotensin II Receptor Involves Phosphorylation of the Receptor Carboxyl Terminus and Correlates with Receptor Internalization Mol. Endocrinol., October 1, 2001; 15(10): 1706 - 1719. [Abstract] [Full Text] [PDF]

				M. Thibonnier, C. L. Plesnicher, K. Berrada, and L. Berti-Mattera Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E81 - E92. [Abstract] [Full Text] [PDF]

				L. Hunyady, Z. Gaborik, G. Vauquelin, and K. J Catt Review: Structural requirements for signalling and regulation of AT1-receptors Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S16 - S23. [PDF]

				Z. Gáborik, M. Szaszák, L. Szidonya, B. Balla, S. Paku, K. J. Catt, A. J. L. Clark, and L. Hunyady {beta}-Arrestin- and Dynamin-Dependent Endocytosis of the AT1 Angiotensin Receptor Mol. Pharmacol., February 1, 2001; 59(2): 239 - 247. [Abstract] [Full Text]

				P. H. Anborgh, J. L. Seachrist, L. B. Dale, and S. S. G. Ferguson Receptor/{beta}-Arrestin Complex Formation and the Differential Trafficking and Resensitization of {beta}2-Adrenergic and Angiotensin II Type 1A Receptors Mol. Endocrinol., December 1, 2000; 14(12): 2040 - 2053. [Abstract] [Full Text]

				J. A. Olivares-Reyes, S. Jayadev, L. Hunyady, K. J. Catt, and R. D. Smith Homologous and Heterologous Phosphorylation of the AT2 Angiotensin Receptor by Protein Kinase C Mol. Pharmacol., November 1, 2000; 58(5): 1156 - 1161. [Abstract] [Full Text]

				J. Ibrahim, A. D. Hughes, and P. S. Sever Action of Angiotensin II on DNA Synthesis by Human Saphenous Vein in Organ Culture Hypertension, November 1, 2000; 36(5): 917 - 921. [Abstract] [Full Text] [PDF]

				M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF]

				W. G. Thomas, H. Qian, C.-S. Chang, and S. Karnik Agonist-induced Phosphorylation of the Angiotensin II (AT1A) Receptor Requires Generation of a Conformation That Is Distinct from the Inositol Phosphate-signaling State J. Biol. Chem., January 28, 2000; 275(4): 2893 - 2900. [Abstract] [Full Text] [PDF]

				A. C. Hanyaloglu, M. Vrecl, K. M. Kroeger, L. E. C. Miles, H. Qian, W. G. Thomas, and K. A. Eidne Casein Kinase II Sites in the Intracellular C-terminal Domain of the Thyrotropin-releasing Hormone Receptor and Chimeric Gonadotropin-releasing Hormone Receptors Contribute to beta -Arrestin-dependent Internalization J. Biol. Chem., May 18, 2001; 276(21): 18066 - 18074. [Abstract] [Full Text] [PDF]

				J. A. Olivares-Reyes, R. D. Smith, L. Hunyady, B. H. Shah, and K. J. Catt Agonist-induced Signaling, Desensitization, and Internalization of a Phosphorylation-deficient AT1A Angiotensin Receptor J. Biol. Chem., October 5, 2001; 276(41): 37761 - 37768. [Abstract] [Full Text] [PDF]

				W. G. Thomas, Y. Brandenburger, D. J. Autelitano, T. Pham, H. Qian, and R. D. Hannan Adenoviral-Directed Expression of the Type 1A Angiotensin Receptor Promotes Cardiomyocyte Hypertrophy via Transactivation of the Epidermal Growth Factor Receptor Circ. Res., February 8, 2002; 90(2): 135 - 142. [Abstract] [Full Text] [PDF]